Announcements Trials
Browse Landscape

Status

Completed 7Enrolling by invitation 2Active not recruiting 2Unknown 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 1408Neoplasms 1142Prostatic Neoplasms 750Lung Neoplasms 626Colorectal Neoplasms 604Carcinoma, Non-Small-Cell Lung 574Carcinoma, Hepatocellular 414Pancreatic Neoplasms 410Leukemia, Myeloid, Acute 399Stomach Neoplasms 365Multiple Myeloma 324Ovarian Neoplasms 313Brain Neoplasms 313Head and Neck Neoplasms 289Neoplasm Metastasis 272Precursor Cell Lymphoblastic Leukemia-Lymphoma 263Rectal Neoplasms 257Recurrence 253Uterine Cervical Neoplasms 249Melanoma 245Esophageal Neoplasms 244Squamous Cell Carcinoma of Head and Neck 236Glioblastoma 232Lymphoma 214Sarcoma 209Colonic Neoplasms 195Urinary Bladder Neoplasms 194Glioma 191Triple Negative Breast Neoplasms 188Hematologic Neoplasms 186

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × OTHER × Prediabetic State × Clear all
NCT03568630 2026-02-02

Blood Markers of Early Pancreas Cancer

University of Nebraska

Recruiting
1,250 enrolled
Gastrointestinal

Diabetes Mellitus, Type 2, Pancreatic Cyst, Prediabetic State, Genetic Predisposition to Disease, Genetic Diseases, Inborn, Pancreatitis, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡